169 related articles for article (PubMed ID: 19753679)
1. Two sampling time profiles for the abbreviated estimation of mycophenolic acid area under the curve in adult renal transplant recipients treated with mycophenolate mofetil and concomitant tacrolimus.
Tutor-Crespo MJ; Hermida J; Romero R; Tutor JC
J Clin Pharm Ther; 2009 Oct; 34(5):531-7. PubMed ID: 19753679
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic efficiency of truncated area under the curve from 0 to 2 h (AUC₀₋₂) of mycophenolic acid in kidney transplant recipients receiving mycophenolate mofetil and concomitant tacrolimus.
Lampón N; Tutor-Crespo MJ; Romero R; Tutor JC
Clin Chem Lab Med; 2011 Jul; 49(7):1167-70. PubMed ID: 21574884
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
[TBL] [Abstract][Full Text] [Related]
4. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.
Pawinski T; Hale M; Korecka M; Fitzsimmons WE; Shaw LM
Clin Chem; 2002 Sep; 48(9):1497-504. PubMed ID: 12194926
[TBL] [Abstract][Full Text] [Related]
5. Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus.
Yamaguchi K; Fukuoka N; Kimura S; Watanabe M; Tani K; Tanaka H; Sofue T; Kosaka S; Inui M; Kakehi Y; Houchi H
Biol Pharm Bull; 2013; 36(6):1036-9. PubMed ID: 23558676
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.
Chen H; Peng C; Yu Z; Shen B; Deng X; Qiu W; Fei Y; Shen C; Zhou G; Yang W; Li H
Clin Pharmacokinet; 2007; 46(2):175-85. PubMed ID: 17253887
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
8. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
[TBL] [Abstract][Full Text] [Related]
9. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
Barraclough KA; Isbel NM; Franklin ME; Lee KJ; Taylor PJ; Campbell SB; Petchey WG; Staatz CE
Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.
Teshima D; Maiguma T; Kaji H; Otsubo K; Kitagawa N; Okabe Y; Sugitani A; Tanaka M; Oishi R
J Clin Pharm Ther; 2008 Apr; 33(2):159-63. PubMed ID: 18315781
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.
Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
Clin Chem; 2001; 47(7):1241-8. PubMed ID: 11427455
[TBL] [Abstract][Full Text] [Related]
14. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
[TBL] [Abstract][Full Text] [Related]
15. Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
Ther Drug Monit; 2009 Aug; 31(4):467-74. PubMed ID: 19571775
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE; Nicholls AJ; Kamm BR
Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
[TBL] [Abstract][Full Text] [Related]
17. Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in Chinese patients undergoing liver transplantation.
Chen H; Gu Z; Chen B; Mao H; Zhang W; Fan Q
Clin Ther; 2008 Dec; 30(12):2387-401. PubMed ID: 19167597
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M
Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111
[TBL] [Abstract][Full Text] [Related]
19. Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy.
Filler G
Transpl Int; 2004 Mar; 17(3):120-5. PubMed ID: 14749919
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.
Muller H; Solari S; Zuniga C; Guerra I; Troncoso J; Ovalle R; Morente J; Pedreros C
Transplant Proc; 2007 Apr; 39(3):596-9. PubMed ID: 17445553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
